• Robust design with three distinct gene targets for SARS-CoV-2: N2, E, RdRP.
• Accurate detection and differentiation of SARS-CoV-2, Flu A, Flu B, and RSV. Results for SARS-CoV-2 in as little as 25 minutes.
• Actionable results from a single sample with less than one minute of hands-on time.
• Standardization of results between the central lab and near-patient testing sites.